Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$112K Buy
+18,321
New +$114K ﹤0.01% 3581
2024
Q2
Sell
-1,651
Closed -$14K 2326
2024
Q1
$14K Buy
+1,651
New +$14.3K ﹤0.01% 2037
2023
Q4
Sell
-1,589
Closed -$15K 2400
2023
Q3
$15K Buy
+1,589
New +$22K ﹤0.01% 2089
2021
Q4
Sell
-2,442
Closed -$333K 3294
2021
Q3
$333K Buy
+2,442
New +$417K ﹤0.01% 2336
2021
Q1
Sell
-3,241
Closed -$583K 2740
2020
Q4
$583K Sell
3,241
-1,610
-33% -$353K 0.01% 943
2020
Q3
$1.05M Buy
+4,851
New +$1.06M 0.03% 497

Other funds holding CLNN

HRT Financial's CLNN Position: Q2 2026 in Review

HRT Financial opened a new position in Clene (CLNN) in Q2 2026: 18,321 shares worth $112K. The stake represents ﹤0.01% of the portfolio and ranks #3581 among its holdings. This is a return to the name: HRT Financial previously reported a position in CLNN as recently as Q1 2024.

HRT Financial first reported a position in CLNN in Q3 2020 and has held it in 6 quarters since. The position peaked at $1.05M in Q3 2020. 33 funds tracked by Wall St. Rank hold CLNN as of Q2 2026.

  • HRT Financial held 18,321 shares of Clene worth $112K as of Q2 2026.
  • Clene was a new HRT Financial position in Q2 2026.
  • Clene made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #3581 holding.
  • HRT Financial first reported a position in Clene in Q3 2020 and has held it in 6 quarters since.
  • HRT Financial's Clene position peaked at $1.05M in Q3 2020.
  • 33 funds tracked by Wall St. Rank held Clene as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.